Prostate cancer screening effectiveness

Persistent link to this item

Statistics
View Statistics

Journal Title

Journal ISSN

Volume Title

Published Date

Publisher

Type

Abstract

Welcome to Public Health Moment from the University of Minnesota. Being screened for prostate cancer does not appear to reduce your chance of dying from the disease. That’s according to a new report from the from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial than 76,000 men. Tim Church, a University of Minnesota expert on cancer screenings, was the study’s lead researcher. <clip: “The key finding is that for 7-year mortality…than the group that was just offered usual care.”> The finding is important because there are negative consequences to screening, Church says. <Clip: “One needs to do a prostate biopsy…such as impotence and incontinence.”> For John Finnegan and Public Health Moment, I’m Mark Engebretson.

Keywords

Description

Runtime 1:30 minutes
This resource is provided for informational purposes only and may not reflect current scientific knowledge or medical recommendations.

Related to

Replaces

License

Series/Report Number

Funding information

Isbn identifier

Doi identifier

Previously Published Citation

Other identifiers

Suggested citation

Engebretson, Mark; Tim Church. (2009). Prostate cancer screening effectiveness. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/257584.

Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.